BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2649132)

  • 1. Prognosis of conjunctival melanomas in relation to histopathological features.
    Fuchs U; Kivelä T; Liesto K; Tarkkanen A
    Br J Cancer; 1989 Feb; 59(2):261-7. PubMed ID: 2649132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant melanoma of the conjunctiva.
    Jeffrey IJ; Lucas DR; McEwan C; Lee WR
    Histopathology; 1986 Apr; 10(4):363-78. PubMed ID: 3710441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma.
    Wuestemeyer H; Sauerwein W; Meller D; Chauvel P; Schueler A; Steuhl KP; Bornfeld N; Anastassiou G
    Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):438-46. PubMed ID: 16133022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in malignant melanoma of the conjunctiva. An anatomo-clinical study of 56 patients].
    Desjardins L; Poncet P; Levy C; Schlienger P; Asselain B; Validire P
    J Fr Ophtalmol; 1999 Apr; 22(3):315-21. PubMed ID: 10337587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases.
    Paridaens AD; Minassian DC; McCartney AC; Hungerford JL
    Br J Ophthalmol; 1994 Apr; 78(4):252-9. PubMed ID: 8199108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and pathological features of 26 cases of conjunctival melanoma].
    Lin JY; Liu D; Li EJ
    Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):308-11. PubMed ID: 20654056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease.
    Tatla T; Hungerford J; Plowman N; Ghufoor K; Keene M
    Laryngoscope; 2005 May; 115(5):817-22. PubMed ID: 15867646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of malignant melanoma.
    Hirano T
    Acta Pathol Jpn; 1986 May; 36(5):733-43. PubMed ID: 3526811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva.
    Lommatzsch PK; Lommatzsch RE; Kirsch I; Fuhrmann P
    Br J Ophthalmol; 1990 Oct; 74(10):615-9. PubMed ID: 2285686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase.
    Burnier MN; McLean IW; Gamel JW
    Cancer; 1991 Aug; 68(4):809-14. PubMed ID: 1855181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
    Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
    Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathology and prognostic factors of conjunctival melanoma].
    Berta-Antalics AI; Kruse FE; Holbach L
    Ophthalmologe; 2015 Nov; 112(11):892, 894-8. PubMed ID: 26531292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant melanoma of the conjunctiva with intraocular extension: a clinicopathological study of three cases.
    Sandinha T; Russell H; Kemp E; Roberts F
    Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):431-6. PubMed ID: 16941140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases.
    De Potter P; Shields CL; Shields JA; Menduke H
    Br J Ophthalmol; 1993 Oct; 77(10):624-30. PubMed ID: 8218029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
    Steuhl KP; Rohrbach JM; Knorr M
    Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local conjunctival metastases from primary conjunctival melanoma: clinico-pathological correlation and implications.
    Mudhar HS; Rennie IG
    Br J Ophthalmol; 2013 Jan; 97(1):33-9. PubMed ID: 23143907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study.
    Anastassiou G; Heiligenhaus A; Bechrakis N; Bader E; Bornfeld N; Steuhl KP
    Br J Ophthalmol; 2002 Feb; 86(2):163-7. PubMed ID: 11815341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up].
    Lommatzsch PK; Werschnik C
    Klin Monbl Augenheilkd; 2002 Oct; 219(10):710-21. PubMed ID: 12447715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.